| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NTR/NTZ185 |
| P698 | PubMed publication ID | 31563966 |
| P2093 | author name string | Mohamadi Sarkar | |
| Qiwei Liang | |||
| Douglas Oliveri | |||
| P2860 | cites work | EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study | Q21089776 |
| Electronic cigarettes: a policy statement from the American Heart Association | Q27026603 | ||
| Estimating the harms of nicotine-containing products using the MCDA approach | Q28237791 | ||
| Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit | Q28244952 | ||
| White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort | Q32062836 | ||
| Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol | Q33583823 | ||
| Levels of selected carcinogens and toxicants in vapour from electronic cigarettes | Q34035935 | ||
| The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes. | Q34256158 | ||
| Electronic cigarettes for smoking cessation: a randomised controlled trial | Q34370483 | ||
| Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study | Q34550683 | ||
| Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health. | Q51731739 | ||
| The potential role of snus in tobacco harm reduction. | Q52295119 | ||
| Are some e-cigarette users "blowing smoke?": Assessing the Accuracy of Self-Reported Smoking Abstinence in Exclusive e-cigarette Users. | Q53069164 | ||
| A Nicotine-Focused Framework for Public Health. | Q53553970 | ||
| Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B2. | Q55286492 | ||
| Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up | Q58719154 | ||
| Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes | Q60955301 | ||
| Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure? | Q83416940 | ||
| Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers | Q84456025 | ||
| Evaluation of spot urine as an alternative to 24h urine collection for determination of biomarkers of exposure to cigarette smoke in adult smokers | Q86628404 | ||
| An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion | Q88136613 | ||
| Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1) | Q91355934 | ||
| Biomarkers of Tobacco Exposure Decrease After Smokers Switch to an E-Cigarette or Nicotine Gum | Q91374424 | ||
| Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study | Q34678680 | ||
| New concepts in chronic obstructive pulmonary disease | Q34930970 | ||
| Chronic obstructive pulmonary disease: molecular and cellularmechanisms | Q35569962 | ||
| Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers | Q35785036 | ||
| Weight gain in smokers after quitting cigarettes: meta-analysis | Q36087096 | ||
| Systemic manifestations in chronic obstructive pulmonary disease. | Q36726350 | ||
| The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US | Q37024750 | ||
| Association between Secondhand Smoke in Hospitality Venues and Urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol Concentrations in Non-Smoking Staff | Q37455742 | ||
| An epidemiologic review of smokeless tobacco health effects and harm reduction potential | Q37606703 | ||
| Tobacco, inflammation, and respiratory tract cancer | Q38013291 | ||
| A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks | Q39260478 | ||
| A longitudinal study of smokeless tobacco use and mortality in the United States. | Q40241671 | ||
| Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy | Q43227509 | ||
| Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers | Q43287620 | ||
| Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6). | Q44210332 | ||
| The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus. | Q44791690 | ||
| Emerging nicotine delivery products. Implications for public health. | Q45996379 | ||
| Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies | Q46234906 | ||
| E-Cigarettes and the Harm-Reduction Continuum | Q50000222 | ||
| A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects | Q50063900 | ||
| Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. | Q50091868 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | biomarker | Q864574 |
| P577 | publication date | 2019-09-30 | |
| P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
| P1476 | title | Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm between Adult E-Vapor Users and Adult Cigarette Smokers |
Search more.